APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dotinurad Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dotinurad Tablets Market Analysis and Forecast 2026-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchDotinurad Tablets Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Dotinurad Tablets Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Dotinurad Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dotinurad Tablets Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Dotinurad Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Dotinurad Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dotinurad Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dotinurad Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dotinurad Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dotinurad Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dotinurad Tablets include Fuji Yakuhin, Mochida Pharmaceutical, Ziska Pharmaceutical, Eisai and General Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dotinurad Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dotinurad Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Dotinurad Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dotinurad Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dotinurad Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dotinurad Tablets sales, projected growth trends, production technology, application and end-user industry.

Dotinurad Tablets Segment by Company

Fuji Yakuhin

Mochida Pharmaceutical

Ziska Pharmaceutical

Eisai

General Pharmaceuticals

Dotinurad Tablets Segment by Type

0.5mg per Tablet

1.0mg per Tablet

2.0mg per Tablet

Dotinurad Tablets Segment by Application

Gout

Hyperuricaemia

Other

Dotinurad Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dotinurad Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dotinurad Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dotinurad Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dotinurad Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dotinurad Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dotinurad Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dotinurad Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.5mg per Tablet Major Manufacturers Table 3. 1.0mg per Tablet Major Manufacturers Table 4. 2.0mg per Tablet Major Manufacturers Table 5. Global Dotinurad Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Gout Major Manufacturers Table 7. Hyperuricaemia Major Manufacturers Table 8. Other Major Manufacturers Table 9. Dotinurad Tablets Industry Trends Table 10. Dotinurad Tablets Industry Drivers Table 11. Dotinurad Tablets Industry Opportunities and Challenges Table 12. Dotinurad Tablets Industry Restraints Table 13. Global Dotinurad Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Dotinurad Tablets Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Dotinurad Tablets Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Dotinurad Tablets Revenue Market Share by Region (2021-2026) Table 17. Global Dotinurad Tablets Revenue Market Share by Region (2027-2032) Table 18. Global Dotinurad Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Dotinurad Tablets Sales by Region (2021-2026) & (K Units) Table 20. Global Dotinurad Tablets Sales by Region (2027-2032) & (K Units) Table 21. Global Dotinurad Tablets Sales Market Share by Region (2021-2026) Table 22. Global Dotinurad Tablets Sales Market Share by Region (2027-2032) Table 23. Global Dotinurad Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Dotinurad Tablets Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Dotinurad Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Dotinurad Tablets Sales Market Share by Manufacturers (2021-2026) Table 27. Global Dotinurad Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Dotinurad Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Dotinurad Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Dotinurad Tablets Manufacturers, Product Type & Application Table 31. Global Dotinurad Tablets Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Dotinurad Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Dotinurad Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Dotinurad Tablets Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Dotinurad Tablets Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Dotinurad Tablets Revenue Market Share by Type (2021-2026) Table 38. Global Dotinurad Tablets Revenue Market Share by Type (2027-2032) Table 39. Global Dotinurad Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Dotinurad Tablets Sales by Type (2021-2026) & (K Units) Table 41. Global Dotinurad Tablets Sales by Type (2027-2032) & (K Units) Table 42. Global Dotinurad Tablets Sales Market Share by Type (2021-2026) Table 43. Global Dotinurad Tablets Sales Market Share by Type (2027-2032) Table 44. Global Dotinurad Tablets Price by Type (2021-2026) & (US$/Unit) Table 45. Global Dotinurad Tablets Price by Type (2027-2032) & (US$/Unit) Table 46. Global Dotinurad Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Dotinurad Tablets Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Dotinurad Tablets Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Dotinurad Tablets Revenue Market Share by Application (2021-2026) Table 50. Global Dotinurad Tablets Revenue Market Share by Application (2027-2032) Table 51. Global Dotinurad Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Dotinurad Tablets Sales by Application (2021-2026) & (K Units) Table 53. Global Dotinurad Tablets Sales by Application (2027-2032) & (K Units) Table 54. Global Dotinurad Tablets Sales Market Share by Application (2021-2026) Table 55. Global Dotinurad Tablets Sales Market Share by Application (2027-2032) Table 56. Global Dotinurad Tablets Price by Application (2021-2026) & (US$/Unit) Table 57. Global Dotinurad Tablets Price by Application (2027-2032) & (US$/Unit) Table 58. Fuji Yakuhin Company Information Table 59. Fuji Yakuhin Business Overview Table 60. Fuji Yakuhin Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Fuji Yakuhin Dotinurad Tablets Product Portfolio Table 62. Fuji Yakuhin Recent Development Table 63. Mochida Pharmaceutical Company Information Table 64. Mochida Pharmaceutical Business Overview Table 65. Mochida Pharmaceutical Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Mochida Pharmaceutical Dotinurad Tablets Product Portfolio Table 67. Mochida Pharmaceutical Recent Development Table 68. Ziska Pharmaceutical Company Information Table 69. Ziska Pharmaceutical Business Overview Table 70. Ziska Pharmaceutical Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Ziska Pharmaceutical Dotinurad Tablets Product Portfolio Table 72. Ziska Pharmaceutical Recent Development Table 73. Eisai Company Information Table 74. Eisai Business Overview Table 75. Eisai Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Eisai Dotinurad Tablets Product Portfolio Table 77. Eisai Recent Development Table 78. General Pharmaceuticals Company Information Table 79. General Pharmaceuticals Business Overview Table 80. General Pharmaceuticals Dotinurad Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. General Pharmaceuticals Dotinurad Tablets Product Portfolio Table 82. General Pharmaceuticals Recent Development Table 83. North America Dotinurad Tablets Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Dotinurad Tablets Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Dotinurad Tablets Sales by Type (2021-2026) & (K Units) Table 86. North America Dotinurad Tablets Sales by Type (2027-2032) & (K Units) Table 87. North America Dotinurad Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 88. North America Dotinurad Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 89. North America Dotinurad Tablets Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Dotinurad Tablets Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Dotinurad Tablets Sales by Application (2021-2026) & (K Units) Table 92. North America Dotinurad Tablets Sales by Application (2027-2032) & (K Units) Table 93. North America Dotinurad Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 94. North America Dotinurad Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 95. North America Dotinurad Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Dotinurad Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 97. North America Dotinurad Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 98. North America Dotinurad Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 99. North America Dotinurad Tablets Sales by Country (2021-2026) & (K Units) Table 100. North America Dotinurad Tablets Sales by Country (2027-2032) & (K Units) Table 101. North America Dotinurad Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 102. North America Dotinurad Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 103. United States Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 104. Canada Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 105. Mexico Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 106. Europe Dotinurad Tablets Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Dotinurad Tablets Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Dotinurad Tablets Sales by Type (2021-2026) & (K Units) Table 109. Europe Dotinurad Tablets Sales by Type (2027-2032) & (K Units) Table 110. Europe Dotinurad Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 111. Europe Dotinurad Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 112. Europe Dotinurad Tablets Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Dotinurad Tablets Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Dotinurad Tablets Sales by Application (2021-2026) & (K Units) Table 115. Europe Dotinurad Tablets Sales by Application (2027-2032) & (K Units) Table 116. Europe Dotinurad Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 117. Europe Dotinurad Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 118. Europe Dotinurad Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Dotinurad Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. Europe Dotinurad Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. Europe Dotinurad Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 122. Europe Dotinurad Tablets Sales by Country (2021-2026) & (K Units) Table 123. Europe Dotinurad Tablets Sales by Country (2027-2032) & (K Units) Table 124. Europe Dotinurad Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 125. Europe Dotinurad Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 126. Germany Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 127. France Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 128. U.K. Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 129. Italy Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 130. Russia Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 131. Spain Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 132. Netherlands Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 133. Switzerland Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 134. Sweden Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 135. Poland Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 136. China Dotinurad Tablets Revenue by Type (2021-2026) & (US$ Million) Table 137. China Dotinurad Tablets Revenue by Type (2027-2032) & (US$ Million) Table 138. China Dotinurad Tablets Sales by Type (2021-2026) & (K Units) Table 139. China Dotinurad Tablets Sales by Type (2027-2032) & (K Units) Table 140. China Dotinurad Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 141. China Dotinurad Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 142. China Dotinurad Tablets Revenue by Application (2021-2026) & (US$ Million) Table 143. China Dotinurad Tablets Revenue by Application (2027-2032) & (US$ Million) Table 144. China Dotinurad Tablets Sales by Application (2021-2026) & (K Units) Table 145. China Dotinurad Tablets Sales by Application (2027-2032) & (K Units) Table 146. China Dotinurad Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 147. China Dotinurad Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 148. Asia Dotinurad Tablets Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Dotinurad Tablets Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Dotinurad Tablets Sales by Type (2021-2026) & (K Units) Table 151. Asia Dotinurad Tablets Sales by Type (2027-2032) & (K Units) Table 152. Asia Dotinurad Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 153. Asia Dotinurad Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 154. Asia Dotinurad Tablets Revenue by Application (2021-2026) & (US$ Million) Table 155. Asia Dotinurad Tablets Revenue by Application (2027-2032) & (US$ Million) Table 156. Asia Dotinurad Tablets Sales by Application (2021-2026) & (K Units) Table 157. Asia Dotinurad Tablets Sales by Application (2027-2032) & (K Units) Table 158. Asia Dotinurad Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 159. Asia Dotinurad Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 160. Asia Dotinurad Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Asia Dotinurad Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Asia Dotinurad Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Asia Dotinurad Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 164. Asia Dotinurad Tablets Sales by Country (2021-2026) & (K Units) Table 165. Asia Dotinurad Tablets Sales by Country (2027-2032) & (K Units) Table 166. Asia Dotinurad Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 167. Asia Dotinurad Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 168. Japan Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 169. South Korea Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 170. India Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 171. Australia Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 172. Taiwan Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 173. Southeast Asia Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 174. SAMEA Dotinurad Tablets Revenue by Type (2021-2026) & (US$ Million) Table 175. SAMEA Dotinurad Tablets Revenue by Type (2027-2032) & (US$ Million) Table 176. SAMEA Dotinurad Tablets Sales by Type (2021-2026) & (K Units) Table 177. SAMEA Dotinurad Tablets Sales by Type (2027-2032) & (K Units) Table 178. SAMEA Dotinurad Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 179. SAMEA Dotinurad Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 180. SAMEA Dotinurad Tablets Revenue by Application (2021-2026) & (US$ Million) Table 181. SAMEA Dotinurad Tablets Revenue by Application (2027-2032) & (US$ Million) Table 182. SAMEA Dotinurad Tablets Sales by Application (2021-2026) & (K Units) Table 183. SAMEA Dotinurad Tablets Sales by Application (2027-2032) & (K Units) Table 184. SAMEA Dotinurad Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 185. SAMEA Dotinurad Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 186. SAMEA Dotinurad Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. SAMEA Dotinurad Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. SAMEA Dotinurad Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. SAMEA Dotinurad Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 190. SAMEA Dotinurad Tablets Sales by Country (2021-2026) & (K Units) Table 191. SAMEA Dotinurad Tablets Sales by Country (2027-2032) & (K Units) Table 192. SAMEA Dotinurad Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 193. SAMEA Dotinurad Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 194. Brazil Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 195. Argentina Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 196. Chile Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 197. Colombia Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 198. Peru Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 199. Saudi Arabia Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 200. Israel Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 201. UAE Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 202. Turkey Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 203. Iran Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 204. Egypt Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Table 205. Key Raw Materials Table 206. Raw Materials Key Suppliers Table 207. Dotinurad Tablets Distributors List Table 208. Dotinurad Tablets Customers List Table 209. Research Programs/Design for This Report Table 210. Authors List of This Report Table 211. Secondary Sources Table 212. Primary Sources List of Figures Figure 1. Dotinurad Tablets Image Figure 2. Global Dotinurad Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dotinurad Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.5mg per Tablet Image Figure 5. 1.0mg per Tablet Image Figure 6. 2.0mg per Tablet Image Figure 7. Global Dotinurad Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Dotinurad Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 9. Gout Image Figure 10. Hyperuricaemia Image Figure 11. Other Image Figure 12. Global Dotinurad Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Dotinurad Tablets Revenue (2021-2032) & (US$ Million) Figure 14. Global Dotinurad Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Dotinurad Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Dotinurad Tablets Revenue Market Share by Region (2021-2032) Figure 17. Global Dotinurad Tablets Sales (2021-2032) & (K Units) Figure 18. Global Dotinurad Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Dotinurad Tablets Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Dotinurad Tablets Sales YoY (2021-2032) & (K Units) Figure 21. Europe Dotinurad Tablets Sales YoY (2021-2032) & (K Units) Figure 22. China Dotinurad Tablets Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Dotinurad Tablets Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Dotinurad Tablets Sales YoY (2021-2032) & (K Units) Figure 25. Global Dotinurad Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Dotinurad Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Dotinurad Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Dotinurad Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Dotinurad Tablets Revenue Market Share by Type (2021-2032) Figure 31. Global Dotinurad Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Dotinurad Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Dotinurad Tablets Sales Market Share by Type (2021-2032) Figure 34. Global Dotinurad Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Dotinurad Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Dotinurad Tablets Revenue Market Share by Application (2021-2032) Figure 37. Global Dotinurad Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Dotinurad Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Dotinurad Tablets Sales Market Share by Application (2021-2032) Figure 40. North America Dotinurad Tablets Revenue Share by Type (2021-2032) Figure 41. North America Dotinurad Tablets Sales Share by Type (2021-2032) Figure 42. North America Dotinurad Tablets Revenue Share by Application (2021-2032) Figure 43. North America Dotinurad Tablets Sales Share by Application (2021-2032) Figure 44. North America Dotinurad Tablets Revenue Share by Country (2021-2032) Figure 45. North America Dotinurad Tablets Sales Share by Country (2021-2032) Figure 46. Europe Dotinurad Tablets Revenue Share by Type (2021-2032) Figure 47. Europe Dotinurad Tablets Sales Share by Type (2021-2032) Figure 48. Europe Dotinurad Tablets Revenue Share by Application (2021-2032) Figure 49. Europe Dotinurad Tablets Sales Share by Application (2021-2032) Figure 50. Europe Dotinurad Tablets Revenue Share by Country (2021-2032) Figure 51. Europe Dotinurad Tablets Sales Share by Country (2021-2032) Figure 52. China Dotinurad Tablets Revenue Share by Type (2021-2032) Figure 53. China Dotinurad Tablets Sales Share by Type (2021-2032) Figure 54. China Dotinurad Tablets Revenue Share by Application (2021-2032) Figure 55. China Dotinurad Tablets Sales Share by Application (2021-2032) Figure 56. Asia Dotinurad Tablets Revenue Share by Type (2021-2032) Figure 57. Asia Dotinurad Tablets Sales Share by Type (2021-2032) Figure 58. Asia Dotinurad Tablets Revenue Share by Application (2021-2032) Figure 59. Asia Dotinurad Tablets Sales Share by Application (2021-2032) Figure 60. Asia Dotinurad Tablets Revenue Share by Country (2021-2032) Figure 61. Asia Dotinurad Tablets Sales Share by Country (2021-2032) Figure 62. SAMEA Dotinurad Tablets Revenue Share by Type (2021-2032) Figure 63. SAMEA Dotinurad Tablets Sales Share by Type (2021-2032) Figure 64. SAMEA Dotinurad Tablets Revenue Share by Application (2021-2032) Figure 65. SAMEA Dotinurad Tablets Sales Share by Application (2021-2032) Figure 66. SAMEA Dotinurad Tablets Revenue Share by Country (2021-2032) Figure 67. SAMEA Dotinurad Tablets Sales Share by Country (2021-2032) Figure 68. Dotinurad Tablets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Dotinurad Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5mg per Tablet
  • 1.0mg per Tablet
  • 2.0mg per Tablet
Applications
  • Gout
  • Hyperuricaemia
  • Other
Companies covered
  • Fuji Yakuhin
  • Mochida Pharmaceutical
  • Ziska Pharmaceutical
  • Eisai
  • General Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dotinurad Tablets Market by Type
  3. 1.2.1 Global Dotinurad Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.5mg per Tablet
  5. 1.2.3 1.0mg per Tablet
  6. 1.2.4 2.0mg per Tablet
  7. 1.3 Dotinurad Tablets Market by Application
  8. 1.3.1 Global Dotinurad Tablets Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Gout
  10. 1.3.3 Hyperuricaemia
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Dotinurad Tablets Market Dynamics
  1. 2.1 Dotinurad Tablets Industry Trends
  2. 2.2 Dotinurad Tablets Industry Drivers
  3. 2.3 Dotinurad Tablets Industry Opportunities and Challenges
  4. 2.4 Dotinurad Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dotinurad Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dotinurad Tablets Revenue by Region
  3. 3.2.1 Global Dotinurad Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dotinurad Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Dotinurad Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Dotinurad Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dotinurad Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dotinurad Tablets Sales by Region
  9. 3.4.1 Global Dotinurad Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dotinurad Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Dotinurad Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Dotinurad Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dotinurad Tablets Revenue by Manufacturers
  2. 4.1.1 Global Dotinurad Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dotinurad Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dotinurad Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dotinurad Tablets Sales by Manufacturers
  6. 4.2.1 Global Dotinurad Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dotinurad Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dotinurad Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dotinurad Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dotinurad Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dotinurad Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dotinurad Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Dotinurad Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dotinurad Tablets Market CR5 and HHI
  16. 4.8.2 2025 Dotinurad Tablets Tier 1, Tier 2, and Tier 3
5 Dotinurad Tablets Market by Type
  1. 5.1 Global Dotinurad Tablets Revenue by Type
  2. 5.1.1 Global Dotinurad Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dotinurad Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dotinurad Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dotinurad Tablets Sales by Type
  6. 5.2.1 Global Dotinurad Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dotinurad Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dotinurad Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dotinurad Tablets Price by Type
6 Dotinurad Tablets Market by Application
  1. 6.1 Global Dotinurad Tablets Revenue by Application
  2. 6.1.1 Global Dotinurad Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dotinurad Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dotinurad Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dotinurad Tablets Sales by Application
  6. 6.2.1 Global Dotinurad Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dotinurad Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dotinurad Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dotinurad Tablets Price by Application
7 Company Profiles
  1. 7.1 Fuji Yakuhin
  2. 7.1.1 Fuji Yakuhin Company Information
  3. 7.1.2 Fuji Yakuhin Business Overview
  4. 7.1.3 Fuji Yakuhin Dotinurad Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Fuji Yakuhin Dotinurad Tablets Product Portfolio
  6. 7.1.5 Fuji Yakuhin Recent Developments
  7. 7.2 Mochida Pharmaceutical
  8. 7.2.1 Mochida Pharmaceutical Company Information
  9. 7.2.2 Mochida Pharmaceutical Business Overview
  10. 7.2.3 Mochida Pharmaceutical Dotinurad Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mochida Pharmaceutical Dotinurad Tablets Product Portfolio
  12. 7.2.5 Mochida Pharmaceutical Recent Developments
  13. 7.3 Ziska Pharmaceutical
  14. 7.3.1 Ziska Pharmaceutical Company Information
  15. 7.3.2 Ziska Pharmaceutical Business Overview
  16. 7.3.3 Ziska Pharmaceutical Dotinurad Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ziska Pharmaceutical Dotinurad Tablets Product Portfolio
  18. 7.3.5 Ziska Pharmaceutical Recent Developments
  19. 7.4 Eisai
  20. 7.4.1 Eisai Company Information
  21. 7.4.2 Eisai Business Overview
  22. 7.4.3 Eisai Dotinurad Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eisai Dotinurad Tablets Product Portfolio
  24. 7.4.5 Eisai Recent Developments
  25. 7.5 General Pharmaceuticals
  26. 7.5.1 General Pharmaceuticals Company Information
  27. 7.5.2 General Pharmaceuticals Business Overview
  28. 7.5.3 General Pharmaceuticals Dotinurad Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 General Pharmaceuticals Dotinurad Tablets Product Portfolio
  30. 7.5.5 General Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Dotinurad Tablets Market Size by Type
  2. 8.1.1 North America Dotinurad Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Dotinurad Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Dotinurad Tablets Price by Type (2021-2032)
  5. 8.2 North America Dotinurad Tablets Market Size by Application
  6. 8.2.1 North America Dotinurad Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Dotinurad Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Dotinurad Tablets Price by Application (2021-2032)
  9. 8.3 North America Dotinurad Tablets Market Size by Country
  10. 8.3.1 North America Dotinurad Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dotinurad Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dotinurad Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dotinurad Tablets Market Size by Type
  2. 9.1.1 Europe Dotinurad Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dotinurad Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Dotinurad Tablets Price by Type (2021-2032)
  5. 9.2 Europe Dotinurad Tablets Market Size by Application
  6. 9.2.1 Europe Dotinurad Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dotinurad Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Dotinurad Tablets Price by Application (2021-2032)
  9. 9.3 Europe Dotinurad Tablets Market Size by Country
  10. 9.3.1 Europe Dotinurad Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dotinurad Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dotinurad Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dotinurad Tablets Market Size by Type
  2. 10.1.1 China Dotinurad Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Dotinurad Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Dotinurad Tablets Price by Type (2021-2032)
  5. 10.2 China Dotinurad Tablets Market Size by Application
  6. 10.2.1 China Dotinurad Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Dotinurad Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Dotinurad Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dotinurad Tablets Market Size by Type
  2. 11.1.1 Asia Dotinurad Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dotinurad Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Dotinurad Tablets Price by Type (2021-2032)
  5. 11.2 Asia Dotinurad Tablets Market Size by Application
  6. 11.2.1 Asia Dotinurad Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dotinurad Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Dotinurad Tablets Price by Application (2021-2032)
  9. 11.3 Asia Dotinurad Tablets Market Size by Country
  10. 11.3.1 Asia Dotinurad Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dotinurad Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dotinurad Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dotinurad Tablets Market Size by Type
  2. 12.1.1 SAMEA Dotinurad Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dotinurad Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dotinurad Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Dotinurad Tablets Market Size by Application
  6. 12.2.1 SAMEA Dotinurad Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dotinurad Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dotinurad Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Dotinurad Tablets Market Size by Country
  10. 12.3.1 SAMEA Dotinurad Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dotinurad Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dotinurad Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dotinurad Tablets Value Chain Analysis
  2. 13.1.1 Dotinurad Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dotinurad Tablets Production Mode & Process
  6. 13.2 Dotinurad Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dotinurad Tablets Distributors
  9. 13.2.3 Dotinurad Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst